3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
4
Genitourinary
2
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
6
Triple Negative Breast Neoplasms
4
Neoplasm Metastasis
2
Carcinoma, Intraductal, Noninfiltrating
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Melanoma
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Ductal, Breast
1
Interventions
pembrolizumab
19
Magnetic Resonance Spectroscopy
17
Docetaxel
13
Specimen Handling
12
Radiotherapy
11
Surveys and Questionnaires
10
Cyclophosphamide
10
Blood Specimen Collection
9
Radiosurgery
8
Paclitaxel
8
Gemcitabine
8
Drug Therapy
8
sargramostim
7
Trastuzumab
7
Nivolumab
7
Carboplatin
7
Injections
6
Early Intervention, Educational
6
Taxes
5
Psychiatric Rehabilitation
5
Methods
5
Interviews as Topic
5
Educational Status
5
spartalizumab
4
motexafin gadolinium
4
aldesleukin
4
X-Rays
4
Therapeutics
4
Standard of Care
4
Spinal Puncture
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Colony-Stimulating Factors
×
Breast
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled